- Home
- PCVX vs JEF Comparison
PCVX vs JEF Comparison
Compare PCVX & JEF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCVX
- JEF
- Stock Information
- Founded
- PCVX 2013
- JEF 1968
- Country
- PCVX United States
- JEF United States
- Employees
- PCVX N/A
- JEF N/A
- Industry
- PCVX Biotechnology: Pharmaceutical Preparations
- JEF Investment Bankers/Brokers/Service
- Sector
- PCVX Health Care
- JEF Finance
- Exchange
- PCVX Nasdaq
- JEF Nasdaq
- Market Cap
- PCVX 11.5B
- JEF 11.8B
- IPO Year
- PCVX 2020
- JEF N/A
- Fundamental
- Price
- PCVX $79.74
- JEF $65.62
- Analyst Decision
- PCVX Strong Buy
- JEF Strong Buy
- Analyst Count
- PCVX 8
- JEF 3
- Target Price
- PCVX $127.71
- JEF $81.67
- AVG Volume (30 Days)
- PCVX 881.2K
- JEF 1.3M
- Earning Date
- PCVX 02-25-2025
- JEF 03-26-2025
- Dividend Yield
- PCVX N/A
- JEF 2.14%
- EPS Growth
- PCVX N/A
- JEF 171.82
- EPS
- PCVX N/A
- JEF 2.99
- Revenue
- PCVX N/A
- JEF $7,010,603,000.00
- Revenue This Year
- PCVX N/A
- JEF $17.38
- Revenue Next Year
- PCVX N/A
- JEF $12.04
- P/E Ratio
- PCVX N/A
- JEF $21.87
- Revenue Growth
- PCVX N/A
- JEF 49.15
- 52 Week Low
- PCVX $58.10
- JEF $40.72
- 52 Week High
- PCVX $121.06
- JEF $82.68
- Technical
- Relative Strength Index (RSI)
- PCVX 36.96
- JEF 27.48
- Support Level
- PCVX $82.03
- JEF $70.19
- Resistance Level
- PCVX $84.10
- JEF $72.20
- Average True Range (ATR)
- PCVX 3.12
- JEF 1.96
- MACD
- PCVX -0.70
- JEF -0.80
- Stochastic Oscillator
- PCVX 1.88
- JEF 5.35
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a vaccine company seeking to improve global health by developing novel vaccines to treat patients suffering from the most common and deadly diseases. Its product comprises. of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-24, VAX-A1, and VAX-PG.
About JEF Jefferies Financial Group Inc.
Jefferies Financial Group Inc is a diversified financial services company. It has two reportable segments; Investment Banking and Capital Markets which is also the majority revenue generating segment, includes securities, commodities, corporate lending, futures and foreign exchange capital markets activities and its investment banking business, which provides underwriting and financial advisory services to clients across different sectors. The Asset Management reportable business segment provides alternative investment management services to investors in the U.S. and overseas and generates investment income from capital invested in and managed by it or its affiliated asset managers.